September 7-9, 2023
Essen / Germany + ONLINE
GREETING WORDS
Dear Colleagues,
Coming up for the tenth time in September 2023: »Master of Disaster«. After last years’ great success, we continue our course: You are cordially invited to join us – on-site in Essen/Germany or online.
The pre-program on Thursday focusses on a variety of senological and gyneco-oncological topics. Amongst it: the traditional breast surgery marking course „Painting by Numbers“.
In particular we are looking forward to present you live surgery again in 2023 – transmitted from two theaters of the KEM | Evang. Kliniken Essen-Mitte to the lecture hall in the Hotel Franz (exclusively for the audience in Essen). As usual, our moderators
there will comment the pictures in a competent way – and will forward your questions to the surgeons, too.
The lecture program is again performed by outstanding representatives from our international and national cooperation partners.
Whether personally in Essen or online: We are looking forward to welcome you!
Yours sincerely,
Prof. Dr. med. Sherko Kümmel
Prof. Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois
Prof. Dr. med. Philipp Harter
Prof. Dr. med. Dr. h.c. Andreas du Bois
Great Symposia every day! Do not miss!
SATELLITE SYMPOSIUM
Chair: S. Kümmel
Thursday, September 7, 11.00 - 12.00 pm
Antibody-Drug Conjugates:
New Era of Treatment for HER2- Breast Cancer
New Era of Treatment for HER2- Breast Cancer
The Potential of ADCs in Breast Cancer
F. Marmé
Real World Experience and Therapy Management with Sacituzumab govitecan
M. Thill
With the kind support of
GILEAD Sciences GmbH
GILEAD Sciences GmbH
SATELLITE SYMPOSIUM
Chair: P. Harter, S. Kümmel
Thursday, September 7, 03.00 - 04.00 pm
What’s New? – Current Developments in Breast and Gynaecological Cancers
Current Challenges in Systemic Therapies of HER2-Negative Breast Cancer
O. Gluz
New Treatment Strategies in Gynaecological Cancers
B. Ataseven
With the kind support of
AstraZeneca GmbH
AstraZeneca GmbH
SATELLITE SYMPOSIUM
Chair: P. Harter, J. Sehouli
Friday, September 8, 03.00 - 04.00 pm
Current Developments and Controversies in Ovarian and Endometrial Cancer – an International Perspective
Case Introduction: Ovarian Cancer
J. Sehouli
To Combine or Not to Combine – How to Choose 1L Maintenance in Ovarian Cancer?
A. González Martín
Panel Discussion
P. Harter, J. Sehouli
Case Introduction: Endometrial Cancer
P. Harter
Advanced/Recurrent EC – What Options Do We Have?
M. R. Mirza
Panel Discussion
P. Harter, J. Sehouli
With the kind support of
GlaxoSmithKline GmbH & Co. KG
GlaxoSmithKline GmbH & Co. KG
EARLY BIRD SYMPOSIUM
Chair: S. Kümmel
Saturday, September 9, 08.15 - 09.00 am
An Underestimated Risk? Challenges in HR+ HER2- eBC from the Patient and Physician Perspective
Risk of Recurrence in the Adjuvant Setting: What Parameters Help us to Assess the Risk?
N. Harbeck
A Dialogue on Risk of Recurrence – Interview with Patient Representatives
[various]
Results from the NATALEE trial
S. Kümmel
With the kind support of
Novartis Pharma GmbH
Novartis Pharma GmbH
SCIENTIFIC SYMPOSIUM
Chair: S. Kümmel
Saturday, September 9, 01.40 - 02.40 pm
State of the Art and Recent Developments of ADC Technology in Breast Cancer
Welcome
S. Kümmel
Status Quo of ADC Therapy and Clinical Experience in HER2-low Metastatic Breast Cancer (mBC)
N. Harbeck
Recent Key Developments of ADC Technology in Breast Cancer
P. Schmid
Round-Table Discussion
With the kind support of
Daiichi Sankyo Deutschland GmbH
and AstraZeneca GmbH
Daiichi Sankyo Deutschland GmbH
and AstraZeneca GmbH
